| Literature DB >> 16183217 |
A-L Berg1, K Ekman, S Belák, M Berg.
Abstract
Feline infectious peritonitis (FIP) is one of the most important viral diseases of cats. International studies estimate that approximately 80% of all purebred cats are infected with the causative agent, feline coronavirus (FCoV). Out of these, 5-12% develop clinical symptoms of FIP. The pathogenesis of the disease is complex with many unresolved issues relating to the role of the immune system. The aim of the present study was to determine the proportions of various inflammatory cell types in FIP lesions by using a panel of cat specific, thoroughly validated, monoclonal antibodies. In addition, the expression of interferon-gamma within the inflammatory lesions was examined by RT-PCR. Our results confirm the mixed nature of the inflammatory reaction in FIP, involving B cells and plasma cells as well as CD4+ and CD8+ T cells. However, one cell type stands out as being the key element in both the "wet" and "dry" forms of FIP: the macrophage. Upregulation of IFN-gamma expression within the inflammatory lesions suggests a local activation of macrophages, which might result in increased viral replication.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16183217 PMCID: PMC7117157 DOI: 10.1016/j.vetmic.2005.07.017
Source DB: PubMed Journal: Vet Microbiol ISSN: 0378-1135 Impact factor: 3.293
Cats included in the study
| Cat no. | Age/sex | Breed | Form of FIP | Duration of illness |
|---|---|---|---|---|
| 1 | 0.4/M | Devon rex | Wet | 2 Weeks |
| 2 | 1.5/M | Persian | Wet | 4 Months |
| 3 | 4/F | Domestic shorthair | Wet | 2 Months |
| 4 | 1/M | Domestic shorthair | Dry | 2 Weeks |
| 5 | 1/M | Birman | Wet | Not known |
| 6 | 1.5/F | Birman | Wet/dry | Not known |
Age in years; M, male; F, female.
Panel of monoclonal antibodies
| Antibody | Dilution used | Source | Specificity | Reference |
|---|---|---|---|---|
| CF54A | 1:800 | VMRD, Pullman, WA, USA | CD3 (pan T) | |
| CAT30A | 1:100 | VMRD | CD4 (T helper) | |
| CAT82A | 1:200 | VMRD | MHC II | |
| F46A | 1:800 | VMRD | CD21 (B cells) | |
| FT2 | 1:50 | Southern Biotechnology, Birmingham, AL, USA | CD8 (cytotoxic T cells) | |
| FIPV3-70 | 1:100 | Customs Monoclonals International, W. Sacramento, CA, USA | FCoV |
Expression of IFN-γ mRNA in types A and B lesions
| Cat no. | Tissue | Type of lesion | Expression of IFN-γ |
|---|---|---|---|
| 4 | Kidney | B | ++++ |
| Liver | None | − | |
| Spleen | Histiocytosis, plasmacytosis | +++ | |
| 5 | Liver | A | − |
| Spleen | A | − | |
| Jejunum | A (severe) | +++ | |
| Lymph node | A (severe) | ++ | |
| 6 | Liver | B | + |
| Lung | A and B | +++ | |
Expression of IFN-γ: −, no detectable expression; +, minimal; ++, slight; +++, moderate; ++++, strong expression.
Fig. 1Histopathological and immunohistochemical characterization of FIP lesions. (a) Diffuse serosal inflammation and fibrinous exsudation (type A lesion) in the liver (cat no. 5). (b) Granuloma formation (type B lesion) in the kidney (cat no. 4). (c) Numerous monocytes/macrophages (red cells) within the same inflammatory area as shown in (a). (d) Numerous monocytes/macrophages (red cells) within the same granuloma as shown in (b). (e) Plasma cells and a multinucleated giant cell (upper right corner) within a type A lesion in the liver (cat no. 6). (f) Inflammatory cells (presumably macrophages) containing FCoV antigen (red cells) within an intestinal granuloma (cat no. 2). FCoV-positive granules are also present extracellularly. Stainings: HE (a, b and e), lectin immunohistochemistry (c and d) and FCoV immunohistochemistry (f). Magnifications: ×100 (a–d), ×200 (f) and ×400 (e).
Fig. 2Mean number of cells expressing different types of CD markers in type A lesions (a) and type B lesions (b). *p < 0.05, **p < 0.005 Mann–Whitney U-test.
Proportions of inflammatory cell populations within FIP types A and B lesions
| CD3 (pan T) | CD4 | CD8 | CD21 (B cells) | Plasma cells | Monocytes/macrophages | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | A | B | A | B | A | B | A | B | A | B | |
| Mean (range) | 2.8 (1–4) | 2.8 (1–4) | 1.7 (1–3) | 1.9 (0–4) | 1.3 (0–2) | 0.7 (0–2) | 0.7 (0–1) | 1.9 (1–3) | 3.5 (3–4) | 2.0 (1–4) | 3.7 (3–4) | 4.0 (4–4) |
| Median | 3.0 | 3.0 | 1.0 | 2.0 | 1.0 | 1.0 | 1.0 | 2.0 | 3.5 | 2.0 | 4.0 | 4.0 |
| NS | NS | NS | 0.0019 | 0.0107 | NS | |||||||
NS, non-significant.
Fig. 3Agarose-gel electrophoresis of interferon-γ RT-PCR products. All PCR reactions were run for 20, 25, 30 and 35 cycles for estimation of relative expression levels. Well number 1, molecular weight marker; 2–5, ConAstimulated feline PBMC; 6, empty; 7–10, feline PBMC without stimulation; 11, empty; 12–15, FIP cat (167/98) liver; 16, empty; 17–20, FIP cat (167/98) lung; 21, Mwmarker; 22, empty; 23, marker; 24–27, FIP cat (125/98) lymph node; 28, empty; 29–32, FIP cat (125/98) spleen; 33, empty; 34–37, FIP cat (125/98) intestine; 38, empty; 39–42, FIP cat (125/98) liver; 43, marker; 44, empty; 45, marker; 46–49, FIP cat (94/97) liver; 50, empty; 51–54, FIP cat (94/97) spleen; 55, empty; 56–59, FIP cat (94/97) kidney; 60, marker; 61–66, empty.